PROTALIX BIOTHERAPEUTICS, INC. (PLX)

[Kronberg]

Hello Spideyboy!
It looks like we've come to a better understanding of some issues. Of course, my idea of selling the company may be completely wrong, but for me, the downgrading of these two scientists speaks volumes.I remember the previous management said something like that "our scientists unique we cannot ride off them and we have no peaple to replace them".
So my logic says apparently these people are not so important for the future of the company.I've now changed my investment priorities and instead of stock market become mortgage lander through a law firm.Reliable and stable monthly income and requires much less my time.I Stopped my PLX DD and I have one question if you are aware of course.The question is: In addition to the three drugs that are on the market today, does Protalix have the real additional competitors? From the past DD I remember the complete fiasco of companies like Idorsia with substrate reduction therapy and Avrobio with gene replacement.Seems Sanofi has in pipeline substrate reduction therapy.Accidentally looked at Avrobio recently. It was a penny stock and only a little bit better right now, but I remember a few years ago it had a market cap of more than $1B and a share price ~ $20.